News Release 

Global study finds women less likely to have heart disease -- and die of it -- than men

First global study to document the risk factors, use of treatment, incidence of heart attacks and strokes and mortality in people from the community, rather than just hospital patients

McMaster University

IMAGE

IMAGE: Marjan Walli-Attaei, PhD, Population Health Research Institute at McMaster University and Hamilton Health Sciences, Hamilton, Canada. view more 

Credit: Population Health Research Institute

HAMILTON, ON (May 20, 2020) -A huge study of more than 160,000 people in 21 countries has found that women are less likely to have cardiovascular disease, and die of it, than men.

It didn't matter if women had, or didn't have, a previous heart attack or stroke. It also didn't matter where they lived around the world, nor their economic status.

The study from the Population Health Research Institute (PHRI) of McMaster University and Hamilton Health Sciences was published in The Lancet today. The information came from the Prospective Urban Rural Epidemiological (PURE) study which followed the participants an average of 10 years.

It is the first global study to document the risk factors, use of treatment, incidence of heart attacks and strokes and mortality in people from the community, rather than just hospital patients.

The study found that women with no history of cardiovascular disease (CVD) were more likely to use preventative medicines, control hypertension and to have quit smoking, compared to men.

"There have been concerns that women with CVD are managed less aggressively than men which could lead to women having poorer prognoses. Some have attributed this to a treatment bias against women," said Marjan Walli-Attaei, the first author and a research fellow at the PHRI.

"In our global study we observed that while prevention strategies were used more often by women, invasive strategies such as percutaneous coronary intervention and coronary artery bypass surgery was used more often for men.

"But, overall, outcomes such as death or a new heart attack or stroke in women were lower than in men. This suggests there may be factors other than a treatment bias against women that contribute to the treatment differences."

Co-author Annika Rosengren, a professor of the University of Gothenburg in Sweden, said that the lower rates of invasive cardiac treatments of women with CVD could be partly explained by the fact that fewer women than men have the type of extensive atherosclerosis that requires medical interventions.

"Other studies have reported that the sex differences in invasive cardiac procedures are not seen once we consider the extent and severity of the coronary artery disease. This suggests that the lower rates of coronary interventions in women is appropriate as they have less extensive disease," she said.

There is, however, substantial concern about the differences in treatment between poorer and richer countries, said Salim Yusuf, professor of medicine at McMaster University and the principal investigator of the PURE study.

"The differences in outcomes in both women and men in low-income countries, where approximately 40% die within 30 days of a heart attack or stroke compared to the less than 10% in high-income countries, is matter of substantial concern. This deserves major attention," he said.

###

More than 30 researchers from 27 countries around the world, including five from Canada, are authors of the research paper from the Prospective Urban Rural Epidemiology (PURE) study led by the Population Health Research Institute.

The PURE study is supported by several Canadian health agencies including Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario and the Ontario Ministry of Health, along with unrestricted grants from several pharmaceutical companies, the PHRI and the Hamilton Health Sciences Research Institute, with additional contributions from various national or local organizations in participating countries.

Post embargo link to the paper.... http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30543-2/fulltext

Photo cut lines:

Marjan Walli-Attaei, PhD, Population Health Research Institute at McMaster University and Hamilton Health Sciences, Hamilton, Canada. Credit Population Health Research Institute

Annika Rosengren, MD, Department of Molecular and Clinical Medicine, Sahlgrenska Academy

University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. Credit Sahlgrenska Academy University of Gothenburg and Sahlgrenska University Hospital.

For more information or to arrange an interview, please contact:

Veronica McGuire
Public Relations, Faculty of Health Sciences
McMaster University
vmcguir@mcmaster.ca
289-776-6952

Roxanne Torbiak
Public Relations & Communications
Hamilton Health Sciences
torbiakr@hhsc.ca
289-795-8604

Author contact information:

Marjan Walli-Attaei, PhD
Population Health Research Institute
Hamilton, Canada
walliam@mcmaster.ca

Annika Rosengren, MD
Department of Molecular and Clinical Medicine
Sahlgrenska Academy
University of Gothenburg and Sahlgrenska University Hospital
Gothenburg, Sweden
Annika.Rosengren@wlab.gu.se

Veronica McGuire
Media Relations
Faculty of Health Sciences
location: HSC-2E47
phone: (905) 525-9140 x 22169
email: vmcguir@mcmaster.ca

McMaster University | Brighter World

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.